March 21, 2022. We generally agree with the USPSTF’s recommendations for preventive statin use, but suggest several improvements. For example, the studies included in the review varied greatly in the types of patients studied and the outcomes measured, and it seems premature to assume the risks are small, especially since even rare risks can be very serious for some patients. We thus urge the USPSTF to recommend that physicians emphasize other strategies to lower cholesterol, such as changes to lifestyle and diet.
Read More »Tag: CVD
NCHR’s Comments on USPSTF’s Draft Recommendation Statement on Behavioral Counseling to Reduce Cardiovascular Disease in Adults Without Known Risk Factors
February 14, 2022: Given the lack of evidence of a more meaningful benefit, we support the “C” grade recommendation that clinicians make decisions for these individual patients about whether to offer or refer them to behavioral counseling.
Read More »NCHR Comments on USPSTF’s Draft Recommendation on Aspirin Use to Prevent Cardiovascular Disease
November 8, 2021. Based on the data, we strongly support the “C” grade recommendation for patients 40 to 59 years old with a 10% or more risk of developing CVD, as well as the “D” grade recommendation for patients 60 and older. However, we urge the USPSTF to include additional information to their recommendation.
Read More »NCHR’s Comments on USPSTF’s Draft Research Plan for Cardiovascular Disease Prevention
June 8, 2020. We support the US Preventive Services Task Force’s efforts to update recommendations based on new scientific evidence.
Read More »